Pharmacokinetic and efficacy of saquinavir mesylate film coated tablet / ritonavir 1500/100 plus tenofovir/emtricitabine 300/200 mg once daily in HIV pretreated patients
Withdrawn prior to enrolment
Phase of Trial: Phase II/III
Latest Information Update: 06 Apr 2015
At a glance
- Drugs Saquinavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- 04 Jun 2010 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov record.
- 14 Mar 2008 The expected completion date for this trial is now 1 Nov 2009, according to ClinicalTrials.gov.
- 14 Mar 2008 Status changed from initiated to recruiting, as reported by ClinicalTrials.gov.